B
ETRM

Bailard’s EnteroMedics Inc. ETRM Stock Holding History

Bailard’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-303
Closed -$83K – 405
2015
Q3 		$83K Hold
303
– – 0.01% 244
2015
Q2 		$197K Hold
303
– – 0.03% 232
2015
Q1 		$291K Hold
303
– – 0.04% 193
2014
Q4 		$451K Hold
303
– – 0.06% 158
2014
Q3 		$391K Hold
303
– – 0.06% 151
2014
Q2 		$496K Hold
303
– – 0.08% 130
2014
Q1 		$578K Sell
303
-323
-52% -$765K 0.09% 122
2013
Q4 		$1.34M Hold
626
– – 0.22% 70
2013
Q3 		$819K Hold
626
– – 0.16% 112
2013
Q2 		$750K Buy
+626
New +$661K 0.14% 119

Other funds holding ETRM

PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bailard's ETRM Position: Q4 2015 in Review

Bailard sold out of EnteroMedics Inc. (ETRM) in Q4 2015, closing a stake of 303 shares — an estimated $83K sold.

Bailard first reported a position in ETRM in Q2 2013 and held it in 10 quarters. The position peaked at $1.34M in Q4 2013. 33 funds tracked by Wall St. Rank hold ETRM as of Q4 2015.

  • Bailard reported no remaining EnteroMedics Inc. position as of Q4 2015 after selling out during the quarter.
  • Bailard sold 303 EnteroMedics Inc. shares in Q4 2015, an estimated $83K.
  • Bailard first reported a position in EnteroMedics Inc. in Q2 2013 and held it in 10 quarters.
  • Bailard's EnteroMedics Inc. position peaked at $1.34M in Q4 2013.
  • 33 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q4 2015.

Based on Bailard's 13F filing for Q4 2015, filed 10 Feb 2016.